Visa Forecast, price target & analysts
Visa Target price 2026 - Analyst rating & recommendation
Visa Classifications & Recommendation
Visa Price Target
| Target Price | $428.40 |
| Price | $361.52 |
| Potential | 18.50% |
| Number of Estimates | 44 |
| 44 Analysts have issued a price target Visa 2027 . The average Visa target price is $428.40. This is 18.50% higher than the current stock price. The highest price target is $483.00 33.60% , the lowest is $339.97 5.96% . | |
| A rating was issued by 51 analysts: 45 Analysts recommend Visa to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2027 of 18.50% . Most analysts recommend the Visa stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
44 Analysts have issued a sales forecast Visa 2026 . The average Visa sales estimate is
This results in the following potential growth metrics:
32 Analysts have issued an Visa EBITDA forecast 2026. The average Visa EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
45 Visa Analysts have issued a net profit forecast 2026. The average Visa net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
45 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is
This results in the following potential growth metrics and future valuations:
Current Visa Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 31 2026 |
| Wolfe Research |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Aug 05 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Aug 03 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Jul 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Aug 31 2026 |
|
Unchanged
Wolfe Research:
Outperform
➜
Outperform
|
Aug 25 2026 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Aug 05 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Aug 03 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Jul 29 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Jul 29 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
